Management of Cardiovascular Disease in Women With Breast Cancer

Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association

(2018) Laxmi S. Mehta et al.   CIRCULATION

Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity

(2018) Mônica Samuel Avila et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Optimal Treatment of Stage B Heart Failure in Cardio-Oncology?

(2018) Ana Barac   JACC-Cardiovascular Imaging

Rationale and Design of the Strain Surveillance of Chemotherapy for Improving Cardiovascular Outcomes (SUCCOUR) Trial

(2018) Tomoko Negishi et al.   JACC-Cardiovascular Imaging

Left Ventricular Dysfunction in Cancer Treatment

(2018) Benjamin Kenigsberg et al.   JACC-Heart Failure

SAFE-HEaRt: A pilot study assessing the cardiac safety of HER2 targeted therapy in patients with HER2 positive breast cancer and reduced left ventricular function.

(2018) Filipa Lynce et al.   JOURNAL OF CLINICAL ONCOLOGY

Ejection Fraction Pros and Cons

(2018) Thomas H. Marwick   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Anthracyclines in Early Breast Cancer: The ABC Trials—USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology)

(2017) Joanne L. Blum et al.   JOURNAL OF CLINICAL ONCOLOGY

Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials

(2017) Carolyn Taylor et al.   JOURNAL OF CLINICAL ONCOLOGY

Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101–Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity

(2017) Edith Pituskin et al.   JOURNAL OF CLINICAL ONCOLOGY

Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

(2017) Saro H. Armenian et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical Practice Recommendations Based on an Updated Review of Breast Cancer Risk Among Women Treated for Childhood Cancer

(2017) Yael E. Derman   Journal of Pediatric Oncology Nursing

11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial

(2017) David Cameron et al.   LANCET

Cardiotoxic effects of anthracycline-based therapy: what is the evidence and what are the potential harms?

(2017) Bennett E Levis et al.   LANCET ONCOLOGY

Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol

(2016) Geeta Gulati et al.   EUROPEAN HEART JOURNAL

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

(2016) Jose Luis Zamorano et al.   EUROPEAN HEART JOURNAL

Proton Therapy for Breast Cancer: Getting to the Heart of the Matter

(2016) Shannon M. MacDonald   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Cardiac Surveillance Guidelines for Trastuzumab-Containing Therapy in Early-Stage Breast Cancer: Getting to the Heart of the Matter

(2016) Chau T. Dang et al.   JOURNAL OF CLINICAL ONCOLOGY

American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline

(2016) Carolyn D. Runowicz et al.   JOURNAL OF CLINICAL ONCOLOGY

Cardiovascular Disease After Aromatase Inhibitor Use

(2016) Reina Haque et al.   JAMA Oncology

Roadmap for biomarkers of cancer therapy cardiotoxicity

(2015) Anthony F Yu et al.   HEART

Exposure of the Heart in Breast Cancer Radiation Therapy: A Systematic Review of Heart Doses Published During 2003 to 2013

(2015) Carolyn W. Taylor et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer

(2015) Sara M. Tolaney et al.   NEW ENGLAND JOURNAL OF MEDICINE

The UK HeartSpare Study (Stage IB): Randomised comparison of a voluntary breath-hold technique and prone radiotherapy after breast conserving surgery

(2015) Frederick R. Bartlett et al.   RADIOTHERAPY AND ONCOLOGY

Risk of cardiovascular adverse events from trastuzumab (Herceptin®) in elderly persons with breast cancer: a population-based study

(2014) H.-T. Tsai et al.   BREAST CANCER RESEARCH AND TREATMENT

Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update

(2014) Harold J. Burstein et al.   JOURNAL OF CLINICAL ONCOLOGY

Use of Myocardial Strain Imaging by Echocardiography for the Early Detection of Cardiotoxicity in Patients During and After Cancer Chemotherapy

(2014) Paaladinesh Thavendiranathan et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

(2014) J. C. Plana et al.   European Heart Journal-Cardiovascular Imaging

2013 ACCF/AHA Guideline for the Management of Heart Failure

(2013) Clyde W. Yancy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer

(2013) Sarah C. Darby et al.   NEW ENGLAND JOURNAL OF MEDICINE

Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) With ACP Plus Trastuzumab As Adjuvant Therapy for Patients With Node-Positive, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

(2012) Edward H. Romond et al.   JOURNAL OF CLINICAL ONCOLOGY

Toxicity of Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer Patients: A Systematic Review and Meta-analysis

(2011) Eitan Amir et al.   JNCI-Journal of the National Cancer Institute